See All Slides - tctmd.com

Slides

Presentation ICI 2012

LMCA Disease – CABG vs. PCI

Presenter: Bagrat Alekyan

December 02, 2012

Presentation

Clinical Outcomes and Surrogate Efficacy Data for a Dose-Escalation Study of Allogeneic Mesenchymal Precursor Cells in Patients with Ischemic or Nonischemic Chronic Heart Failure

Presenter: Emerson C. Perin

January 27, 2013

Presentation Cell Therapy 2013

REVIVE: Retrograde Bone Marrow-Derived Cells for Dilated Cardiomyopathy

Presenter: Amit N. Patel

January 22, 2013

Presentation Cell Therapy 2013

IMPACT Clinical Trial Program: Findings and Strategic Update

Presenter: Jay H. Traverse

January 22, 2013

Presentation CTO 2013

Complex Antegrade CTO PCI

Presenter: Georgios Sianos

February 20, 2013

Presentation CTO 2013

Hybrid Strategies for Retrograde and Antegrade Lesion Crossing Based on Anatomy

Presenter: David Daniels

February 21, 2013

Presentation CTO 2013

Donor Vessel Dissection and Thrombosis

Presenter: St?phane Rinfret

February 21, 2013

Presentation

The Impact of Coronary Bifurcation Stenting Strategy on Health-Related Functional Status

Presenter: 196862|Alex Sirker

February 21, 2013

Presentation PCI Outcomes 2013

Perspectives on the Selection and Duration of Dual Antiplatelet Therapy

Presenter: Dominick J. Angiolillo

March 07, 2013

Presentation TCT 2015

Scotland Presents: How Did I Treat This Case?

Presenter: Graham A. Cassel, Nick Curzen, Niall T. Mulvihill, Margaret B. McEntegart

October 12, 2015

Advertisement

Slides

LMCA Disease – CABG vs. PCI

Clinical Outcomes and Surrogate Efficacy Data for a Dose-Escalation Study of Allogeneic Mesenchymal Precursor Cells in Patients with Ischemic or Nonischemic Chronic Heart Failure

REVIVE: Retrograde Bone Marrow-Derived Cells for Dilated Cardiomyopathy

IMPACT Clinical Trial Program: Findings and Strategic Update

Complex Antegrade CTO PCI

Hybrid Strategies for Retrograde and Antegrade Lesion Crossing Based on Anatomy

Donor Vessel Dissection and Thrombosis

The Impact of Coronary Bifurcation Stenting Strategy on Health-Related Functional Status

Perspectives on the Selection and Duration of Dual Antiplatelet Therapy

Scotland Presents: How Did I Treat This Case?

Search Slides

Advertisement

Advertisement

Slides

Search Slides

Sign Up for Our Newsletter

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content